These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38248077)

  • 41. "One line": A method for differential diagnosis of parkinsonian syndromes.
    Sako W; Abe T; Haji S; Murakami N; Osaki Y; Izumi Y; Harada M; Kaji R
    Acta Neurol Scand; 2019 Sep; 140(3):229-235. PubMed ID: 31225648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
    Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
    Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential diagnosis value of sympathetic skin response and cutaneous silent period on early-stage multiple system atrophy and Parkinson disease.
    Xie C; He P; Gan R; Chen J; He X; Yang R; Wang L; Nie K; Wang L
    Parkinsonism Relat Disord; 2024 Jun; 126():107046. PubMed ID: 39002210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.
    Kim BC; Choi SM; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Yoon W
    Neurol Sci; 2017 Apr; 38(4):627-633. PubMed ID: 28078564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
    PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphology and signal changes of the lentiform nucleus based on susceptibility weighted imaging in parkinsonism-predominant multiple system atrophy.
    Ren Q; Meng X; Zhang B; Zhang J; Shuai X; Nan X; Zhao C
    Parkinsonism Relat Disord; 2020 Dec; 81():194-199. PubMed ID: 33189038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
    Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
    Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology.
    Terao Y; Fukuda H; Tokushige S; Inomata-Terada S; Yugeta A; Hamada M; Ichikawa Y; Hanajima R; Ugawa Y
    Clin Neurophysiol; 2016 Feb; 127(2):1491-1502. PubMed ID: 26350408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rates of change of pons and middle cerebellar peduncle diameters are diagnostic of multiple system atrophy of the cerebellar type.
    Stephen CD; Vangel M; Gupta AS; MacMore JP; Schmahmann JD
    Brain Commun; 2024; 6(1):fcae019. PubMed ID: 38410617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebellar resting-state functional connectivity in Parkinson's disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level.
    Baggio HC; Abos A; Segura B; Campabadal A; Uribe C; Giraldo DM; Perez-Soriano A; Muñoz E; Compta Y; Junque C; Marti MJ
    Neuroimage Clin; 2019; 22():101720. PubMed ID: 30785051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage.
    Baschieri F; Calandra-Buonaura G; Doria A; Mastrolilli F; Palareti A; Barletta G; Solieri L; Guaraldi P; Martinelli P; Cortelli P
    Parkinsonism Relat Disord; 2015 May; 21(5):477-82. PubMed ID: 25749354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
    Pellecchia MT; Longo K; Pivonello R; Lucetti C; Marchese R; Spampani A; Manfredi M; Epifanio A; Sensi M; Scaravilli T; Bracco F; Eleopra R; Morgante L; Donati E; Marconi R; Abbruzzese G; Bonuccelli U; Zappia M; Colao A; Barone P
    Ann Neurol; 2006 Nov; 60(5):611-615. PubMed ID: 16958123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy.
    Ito S; Shirai W; Hattori T
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):689-92. PubMed ID: 19147717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphometry MRI in the differential diagnosis of parkinsonian syndromes.
    Gama RL; Távora DF; Bomfim RC; Silva CE; Bruin VM; Bruin PF
    Arq Neuropsiquiatr; 2010 Jun; 68(3):333-8. PubMed ID: 20602031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional connectome automatically differentiates multiple system atrophy (parkinsonian type) from idiopathic Parkinson's disease at early stages.
    Chen B; Cui W; Wang S; Sun A; Yu H; Liu Y; He J; Fan G
    Hum Brain Mapp; 2023 Apr; 44(6):2176-2190. PubMed ID: 36661217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.